Medical Care
Global Pharmaceutical R&D Outsourcing Services (CRO) Market Research Report 2025
- Jan 16, 26
- ID: 676162
- Pages: 87
- Figures: 86
- Views: 8
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical R&D Outsourcing Services (CRO), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical R&D Outsourcing Services (CRO).
The Pharmaceutical R&D Outsourcing Services (CRO) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical R&D Outsourcing Services (CRO) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical R&D Outsourcing Services (CRO) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
IQVIA HOLDINGS
ICON (incl. PRA Health)
PPD(Pharmaceutical Product Development)
Laboratory Corporation
Syneos Health
Parexel
Covance
Charles River Laboratories
Wuxi AppTec
Pharmaron Inc.
Hangzhou Tigermed Consulting
IQVIA
Joinn Laboratories (China)
Segment by Type
Chemical Drug Research And Development
Biological Drug Research And Development
Traditional Chinese Medicine Research And Development
Segment by Application
Drug Discovery And Early Research
Preclinical Research
Clinical Trials
Post-Marketing Follow-Up
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical R&D Outsourcing Services (CRO) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Pharmaceutical R&D Outsourcing Services (CRO) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical R&D Outsourcing Services (CRO) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical R&D Outsourcing Services (CRO) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
IQVIA HOLDINGS
ICON (incl. PRA Health)
PPD(Pharmaceutical Product Development)
Laboratory Corporation
Syneos Health
Parexel
Covance
Charles River Laboratories
Wuxi AppTec
Pharmaron Inc.
Hangzhou Tigermed Consulting
IQVIA
Joinn Laboratories (China)
Segment by Type
Chemical Drug Research And Development
Biological Drug Research And Development
Traditional Chinese Medicine Research And Development
Segment by Application
Drug Discovery And Early Research
Preclinical Research
Clinical Trials
Post-Marketing Follow-Up
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical R&D Outsourcing Services (CRO) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Chemical Drug Research And Development
1.2.3 Biological Drug Research And Development
1.2.4 Traditional Chinese Medicine Research And Development
1.3 Market by Application
1.3.1 Global Pharmaceutical R&D Outsourcing Services (CRO) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Drug Discovery And Early Research
1.3.3 Preclinical Research
1.3.4 Clinical Trials
1.3.5 Post-Marketing Follow-Up
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical R&D Outsourcing Services (CRO) Market Perspective (2020-2031)
2.2 Global Pharmaceutical R&D Outsourcing Services (CRO) Growth Trends by Region
2.2.1 Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pharmaceutical R&D Outsourcing Services (CRO) Historic Market Size by Region (2020-2025)
2.2.3 Pharmaceutical R&D Outsourcing Services (CRO) Forecasted Market Size by Region (2026-2031)
2.3 Pharmaceutical R&D Outsourcing Services (CRO) Market Dynamics
2.3.1 Pharmaceutical R&D Outsourcing Services (CRO) Industry Trends
2.3.2 Pharmaceutical R&D Outsourcing Services (CRO) Market Drivers
2.3.3 Pharmaceutical R&D Outsourcing Services (CRO) Market Challenges
2.3.4 Pharmaceutical R&D Outsourcing Services (CRO) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical R&D Outsourcing Services (CRO) Players by Revenue
3.1.1 Global Top Pharmaceutical R&D Outsourcing Services (CRO) Players by Revenue (2020-2025)
3.1.2 Global Pharmaceutical R&D Outsourcing Services (CRO) Revenue Market Share by Players (2020-2025)
3.2 Global Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharmaceutical R&D Outsourcing Services (CRO) Revenue
3.4 Global Pharmaceutical R&D Outsourcing Services (CRO) Market Concentration Ratio
3.4.1 Global Pharmaceutical R&D Outsourcing Services (CRO) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical R&D Outsourcing Services (CRO) Revenue in 2024
3.5 Global Key Players of Pharmaceutical R&D Outsourcing Services (CRO) Head office and Area Served
3.6 Global Key Players of Pharmaceutical R&D Outsourcing Services (CRO), Product and Application
3.7 Global Key Players of Pharmaceutical R&D Outsourcing Services (CRO), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical R&D Outsourcing Services (CRO) Breakdown Data by Type
4.1 Global Pharmaceutical R&D Outsourcing Services (CRO) Historic Market Size by Type (2020-2025)
4.2 Global Pharmaceutical R&D Outsourcing Services (CRO) Forecasted Market Size by Type (2026-2031)
5 Pharmaceutical R&D Outsourcing Services (CRO) Breakdown Data by Application
5.1 Global Pharmaceutical R&D Outsourcing Services (CRO) Historic Market Size by Application (2020-2025)
5.2 Global Pharmaceutical R&D Outsourcing Services (CRO) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pharmaceutical R&D Outsourcing Services (CRO) Market Size (2020-2031)
6.2 North America Pharmaceutical R&D Outsourcing Services (CRO) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2020-2025)
6.4 North America Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size (2020-2031)
7.2 Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2020-2025)
7.4 Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical R&D Outsourcing Services (CRO) Market Size (2020-2031)
8.2 Asia-Pacific Pharmaceutical R&D Outsourcing Services (CRO) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Region (2020-2025)
8.4 Asia-Pacific Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical R&D Outsourcing Services (CRO) Market Size (2020-2031)
9.2 Latin America Pharmaceutical R&D Outsourcing Services (CRO) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2020-2025)
9.4 Latin America Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size (2020-2031)
10.2 Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2020-2025)
10.4 Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IQVIA HOLDINGS
11.1.1 IQVIA HOLDINGS Company Details
11.1.2 IQVIA HOLDINGS Business Overview
11.1.3 IQVIA HOLDINGS Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.1.4 IQVIA HOLDINGS Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
11.1.5 IQVIA HOLDINGS Recent Development
11.2 ICON (incl. PRA Health)
11.2.1 ICON (incl. PRA Health) Company Details
11.2.2 ICON (incl. PRA Health) Business Overview
11.2.3 ICON (incl. PRA Health) Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.2.4 ICON (incl. PRA Health) Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
11.2.5 ICON (incl. PRA Health) Recent Development
11.3 PPD(Pharmaceutical Product Development)
11.3.1 PPD(Pharmaceutical Product Development) Company Details
11.3.2 PPD(Pharmaceutical Product Development) Business Overview
11.3.3 PPD(Pharmaceutical Product Development) Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.3.4 PPD(Pharmaceutical Product Development) Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
11.3.5 PPD(Pharmaceutical Product Development) Recent Development
11.4 Laboratory Corporation
11.4.1 Laboratory Corporation Company Details
11.4.2 Laboratory Corporation Business Overview
11.4.3 Laboratory Corporation Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.4.4 Laboratory Corporation Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
11.4.5 Laboratory Corporation Recent Development
11.5 Syneos Health
11.5.1 Syneos Health Company Details
11.5.2 Syneos Health Business Overview
11.5.3 Syneos Health Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.5.4 Syneos Health Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
11.5.5 Syneos Health Recent Development
11.6 Parexel
11.6.1 Parexel Company Details
11.6.2 Parexel Business Overview
11.6.3 Parexel Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.6.4 Parexel Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
11.6.5 Parexel Recent Development
11.7 Covance
11.7.1 Covance Company Details
11.7.2 Covance Business Overview
11.7.3 Covance Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.7.4 Covance Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
11.7.5 Covance Recent Development
11.8 Charles River Laboratories
11.8.1 Charles River Laboratories Company Details
11.8.2 Charles River Laboratories Business Overview
11.8.3 Charles River Laboratories Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.8.4 Charles River Laboratories Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
11.8.5 Charles River Laboratories Recent Development
11.9 Wuxi AppTec
11.9.1 Wuxi AppTec Company Details
11.9.2 Wuxi AppTec Business Overview
11.9.3 Wuxi AppTec Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.9.4 Wuxi AppTec Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
11.9.5 Wuxi AppTec Recent Development
11.10 Pharmaron Inc.
11.10.1 Pharmaron Inc. Company Details
11.10.2 Pharmaron Inc. Business Overview
11.10.3 Pharmaron Inc. Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.10.4 Pharmaron Inc. Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
11.10.5 Pharmaron Inc. Recent Development
11.11 Hangzhou Tigermed Consulting
11.11.1 Hangzhou Tigermed Consulting Company Details
11.11.2 Hangzhou Tigermed Consulting Business Overview
11.11.3 Hangzhou Tigermed Consulting Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.11.4 Hangzhou Tigermed Consulting Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
11.11.5 Hangzhou Tigermed Consulting Recent Development
11.12 IQVIA
11.12.1 IQVIA Company Details
11.12.2 IQVIA Business Overview
11.12.3 IQVIA Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.12.4 IQVIA Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
11.12.5 IQVIA Recent Development
11.13 Joinn Laboratories (China)
11.13.1 Joinn Laboratories (China) Company Details
11.13.2 Joinn Laboratories (China) Business Overview
11.13.3 Joinn Laboratories (China) Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.13.4 Joinn Laboratories (China) Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
11.13.5 Joinn Laboratories (China) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Chemical Drug Research And Development
1.2.3 Biological Drug Research And Development
1.2.4 Traditional Chinese Medicine Research And Development
1.3 Market by Application
1.3.1 Global Pharmaceutical R&D Outsourcing Services (CRO) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Drug Discovery And Early Research
1.3.3 Preclinical Research
1.3.4 Clinical Trials
1.3.5 Post-Marketing Follow-Up
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical R&D Outsourcing Services (CRO) Market Perspective (2020-2031)
2.2 Global Pharmaceutical R&D Outsourcing Services (CRO) Growth Trends by Region
2.2.1 Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pharmaceutical R&D Outsourcing Services (CRO) Historic Market Size by Region (2020-2025)
2.2.3 Pharmaceutical R&D Outsourcing Services (CRO) Forecasted Market Size by Region (2026-2031)
2.3 Pharmaceutical R&D Outsourcing Services (CRO) Market Dynamics
2.3.1 Pharmaceutical R&D Outsourcing Services (CRO) Industry Trends
2.3.2 Pharmaceutical R&D Outsourcing Services (CRO) Market Drivers
2.3.3 Pharmaceutical R&D Outsourcing Services (CRO) Market Challenges
2.3.4 Pharmaceutical R&D Outsourcing Services (CRO) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical R&D Outsourcing Services (CRO) Players by Revenue
3.1.1 Global Top Pharmaceutical R&D Outsourcing Services (CRO) Players by Revenue (2020-2025)
3.1.2 Global Pharmaceutical R&D Outsourcing Services (CRO) Revenue Market Share by Players (2020-2025)
3.2 Global Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharmaceutical R&D Outsourcing Services (CRO) Revenue
3.4 Global Pharmaceutical R&D Outsourcing Services (CRO) Market Concentration Ratio
3.4.1 Global Pharmaceutical R&D Outsourcing Services (CRO) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical R&D Outsourcing Services (CRO) Revenue in 2024
3.5 Global Key Players of Pharmaceutical R&D Outsourcing Services (CRO) Head office and Area Served
3.6 Global Key Players of Pharmaceutical R&D Outsourcing Services (CRO), Product and Application
3.7 Global Key Players of Pharmaceutical R&D Outsourcing Services (CRO), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical R&D Outsourcing Services (CRO) Breakdown Data by Type
4.1 Global Pharmaceutical R&D Outsourcing Services (CRO) Historic Market Size by Type (2020-2025)
4.2 Global Pharmaceutical R&D Outsourcing Services (CRO) Forecasted Market Size by Type (2026-2031)
5 Pharmaceutical R&D Outsourcing Services (CRO) Breakdown Data by Application
5.1 Global Pharmaceutical R&D Outsourcing Services (CRO) Historic Market Size by Application (2020-2025)
5.2 Global Pharmaceutical R&D Outsourcing Services (CRO) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pharmaceutical R&D Outsourcing Services (CRO) Market Size (2020-2031)
6.2 North America Pharmaceutical R&D Outsourcing Services (CRO) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2020-2025)
6.4 North America Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size (2020-2031)
7.2 Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2020-2025)
7.4 Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical R&D Outsourcing Services (CRO) Market Size (2020-2031)
8.2 Asia-Pacific Pharmaceutical R&D Outsourcing Services (CRO) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Region (2020-2025)
8.4 Asia-Pacific Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical R&D Outsourcing Services (CRO) Market Size (2020-2031)
9.2 Latin America Pharmaceutical R&D Outsourcing Services (CRO) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2020-2025)
9.4 Latin America Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size (2020-2031)
10.2 Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2020-2025)
10.4 Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IQVIA HOLDINGS
11.1.1 IQVIA HOLDINGS Company Details
11.1.2 IQVIA HOLDINGS Business Overview
11.1.3 IQVIA HOLDINGS Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.1.4 IQVIA HOLDINGS Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
11.1.5 IQVIA HOLDINGS Recent Development
11.2 ICON (incl. PRA Health)
11.2.1 ICON (incl. PRA Health) Company Details
11.2.2 ICON (incl. PRA Health) Business Overview
11.2.3 ICON (incl. PRA Health) Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.2.4 ICON (incl. PRA Health) Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
11.2.5 ICON (incl. PRA Health) Recent Development
11.3 PPD(Pharmaceutical Product Development)
11.3.1 PPD(Pharmaceutical Product Development) Company Details
11.3.2 PPD(Pharmaceutical Product Development) Business Overview
11.3.3 PPD(Pharmaceutical Product Development) Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.3.4 PPD(Pharmaceutical Product Development) Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
11.3.5 PPD(Pharmaceutical Product Development) Recent Development
11.4 Laboratory Corporation
11.4.1 Laboratory Corporation Company Details
11.4.2 Laboratory Corporation Business Overview
11.4.3 Laboratory Corporation Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.4.4 Laboratory Corporation Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
11.4.5 Laboratory Corporation Recent Development
11.5 Syneos Health
11.5.1 Syneos Health Company Details
11.5.2 Syneos Health Business Overview
11.5.3 Syneos Health Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.5.4 Syneos Health Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
11.5.5 Syneos Health Recent Development
11.6 Parexel
11.6.1 Parexel Company Details
11.6.2 Parexel Business Overview
11.6.3 Parexel Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.6.4 Parexel Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
11.6.5 Parexel Recent Development
11.7 Covance
11.7.1 Covance Company Details
11.7.2 Covance Business Overview
11.7.3 Covance Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.7.4 Covance Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
11.7.5 Covance Recent Development
11.8 Charles River Laboratories
11.8.1 Charles River Laboratories Company Details
11.8.2 Charles River Laboratories Business Overview
11.8.3 Charles River Laboratories Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.8.4 Charles River Laboratories Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
11.8.5 Charles River Laboratories Recent Development
11.9 Wuxi AppTec
11.9.1 Wuxi AppTec Company Details
11.9.2 Wuxi AppTec Business Overview
11.9.3 Wuxi AppTec Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.9.4 Wuxi AppTec Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
11.9.5 Wuxi AppTec Recent Development
11.10 Pharmaron Inc.
11.10.1 Pharmaron Inc. Company Details
11.10.2 Pharmaron Inc. Business Overview
11.10.3 Pharmaron Inc. Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.10.4 Pharmaron Inc. Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
11.10.5 Pharmaron Inc. Recent Development
11.11 Hangzhou Tigermed Consulting
11.11.1 Hangzhou Tigermed Consulting Company Details
11.11.2 Hangzhou Tigermed Consulting Business Overview
11.11.3 Hangzhou Tigermed Consulting Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.11.4 Hangzhou Tigermed Consulting Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
11.11.5 Hangzhou Tigermed Consulting Recent Development
11.12 IQVIA
11.12.1 IQVIA Company Details
11.12.2 IQVIA Business Overview
11.12.3 IQVIA Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.12.4 IQVIA Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
11.12.5 IQVIA Recent Development
11.13 Joinn Laboratories (China)
11.13.1 Joinn Laboratories (China) Company Details
11.13.2 Joinn Laboratories (China) Business Overview
11.13.3 Joinn Laboratories (China) Pharmaceutical R&D Outsourcing Services (CRO) Introduction
11.13.4 Joinn Laboratories (China) Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
11.13.5 Joinn Laboratories (China) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Chemical Drug Research And Development
Table 3. Key Players of Biological Drug Research And Development
Table 4. Key Players of Traditional Chinese Medicine Research And Development
Table 5. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Region (2020-2025)
Table 9. Global Pharmaceutical R&D Outsourcing Services (CRO) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Region (2026-2031)
Table 11. Pharmaceutical R&D Outsourcing Services (CRO) Market Trends
Table 12. Pharmaceutical R&D Outsourcing Services (CRO) Market Drivers
Table 13. Pharmaceutical R&D Outsourcing Services (CRO) Market Challenges
Table 14. Pharmaceutical R&D Outsourcing Services (CRO) Market Restraints
Table 15. Global Pharmaceutical R&D Outsourcing Services (CRO) Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Players (2020-2025)
Table 17. Global Top Pharmaceutical R&D Outsourcing Services (CRO) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical R&D Outsourcing Services (CRO) as of 2024)
Table 18. Ranking of Global Top Pharmaceutical R&D Outsourcing Services (CRO) Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Pharmaceutical R&D Outsourcing Services (CRO) Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Pharmaceutical R&D Outsourcing Services (CRO), Headquarters and Area Served
Table 21. Global Key Players of Pharmaceutical R&D Outsourcing Services (CRO), Product and Application
Table 22. Global Key Players of Pharmaceutical R&D Outsourcing Services (CRO), Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Pharmaceutical R&D Outsourcing Services (CRO) Revenue Market Share by Type (2020-2025)
Table 26. Global Pharmaceutical R&D Outsourcing Services (CRO) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Pharmaceutical R&D Outsourcing Services (CRO) Revenue Market Share by Type (2026-2031)
Table 28. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Pharmaceutical R&D Outsourcing Services (CRO) Revenue Market Share by Application (2020-2025)
Table 30. Global Pharmaceutical R&D Outsourcing Services (CRO) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Pharmaceutical R&D Outsourcing Services (CRO) Revenue Market Share by Application (2026-2031)
Table 32. North America Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2026-2031) & (US$ Million)
Table 47. IQVIA HOLDINGS Company Details
Table 48. IQVIA HOLDINGS Business Overview
Table 49. IQVIA HOLDINGS Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 50. IQVIA HOLDINGS Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025) & (US$ Million)
Table 51. IQVIA HOLDINGS Recent Development
Table 52. ICON (incl. PRA Health) Company Details
Table 53. ICON (incl. PRA Health) Business Overview
Table 54. ICON (incl. PRA Health) Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 55. ICON (incl. PRA Health) Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025) & (US$ Million)
Table 56. ICON (incl. PRA Health) Recent Development
Table 57. PPD(Pharmaceutical Product Development) Company Details
Table 58. PPD(Pharmaceutical Product Development) Business Overview
Table 59. PPD(Pharmaceutical Product Development) Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 60. PPD(Pharmaceutical Product Development) Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025) & (US$ Million)
Table 61. PPD(Pharmaceutical Product Development) Recent Development
Table 62. Laboratory Corporation Company Details
Table 63. Laboratory Corporation Business Overview
Table 64. Laboratory Corporation Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 65. Laboratory Corporation Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025) & (US$ Million)
Table 66. Laboratory Corporation Recent Development
Table 67. Syneos Health Company Details
Table 68. Syneos Health Business Overview
Table 69. Syneos Health Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 70. Syneos Health Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025) & (US$ Million)
Table 71. Syneos Health Recent Development
Table 72. Parexel Company Details
Table 73. Parexel Business Overview
Table 74. Parexel Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 75. Parexel Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025) & (US$ Million)
Table 76. Parexel Recent Development
Table 77. Covance Company Details
Table 78. Covance Business Overview
Table 79. Covance Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 80. Covance Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025) & (US$ Million)
Table 81. Covance Recent Development
Table 82. Charles River Laboratories Company Details
Table 83. Charles River Laboratories Business Overview
Table 84. Charles River Laboratories Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 85. Charles River Laboratories Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025) & (US$ Million)
Table 86. Charles River Laboratories Recent Development
Table 87. Wuxi AppTec Company Details
Table 88. Wuxi AppTec Business Overview
Table 89. Wuxi AppTec Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 90. Wuxi AppTec Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025) & (US$ Million)
Table 91. Wuxi AppTec Recent Development
Table 92. Pharmaron Inc. Company Details
Table 93. Pharmaron Inc. Business Overview
Table 94. Pharmaron Inc. Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 95. Pharmaron Inc. Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025) & (US$ Million)
Table 96. Pharmaron Inc. Recent Development
Table 97. Hangzhou Tigermed Consulting Company Details
Table 98. Hangzhou Tigermed Consulting Business Overview
Table 99. Hangzhou Tigermed Consulting Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 100. Hangzhou Tigermed Consulting Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025) & (US$ Million)
Table 101. Hangzhou Tigermed Consulting Recent Development
Table 102. IQVIA Company Details
Table 103. IQVIA Business Overview
Table 104. IQVIA Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 105. IQVIA Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025) & (US$ Million)
Table 106. IQVIA Recent Development
Table 107. Joinn Laboratories (China) Company Details
Table 108. Joinn Laboratories (China) Business Overview
Table 109. Joinn Laboratories (China) Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 110. Joinn Laboratories (China) Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025) & (US$ Million)
Table 111. Joinn Laboratories (China) Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
Table 115. Authors List of This Report
List of Figures
Figure 1. Pharmaceutical R&D Outsourcing Services (CRO) Picture
Figure 2. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Type: 2024 VS 2031
Figure 4. Chemical Drug Research And Development Features
Figure 5. Biological Drug Research And Development Features
Figure 6. Traditional Chinese Medicine Research And Development Features
Figure 7. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Application: 2024 VS 2031
Figure 9. Drug Discovery And Early Research Case Studies
Figure 10. Preclinical Research Case Studies
Figure 11. Clinical Trials Case Studies
Figure 12. Post-Marketing Follow-Up Case Studies
Figure 13. Other Case Studies
Figure 14. Pharmaceutical R&D Outsourcing Services (CRO) Report Years Considered
Figure 15. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Region: 2024 VS 2031
Figure 18. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Players in 2024
Figure 19. Global Top Pharmaceutical R&D Outsourcing Services (CRO) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical R&D Outsourcing Services (CRO) as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Pharmaceutical R&D Outsourcing Services (CRO) Revenue in 2024
Figure 21. North America Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Country (2020-2031)
Figure 23. United States Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Country (2020-2031)
Figure 27. Germany Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Region (2020-2031)
Figure 35. China Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Country (2020-2031)
Figure 43. Mexico Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Country (2020-2031)
Figure 47. Turkey Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. IQVIA HOLDINGS Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
Figure 51. ICON (incl. PRA Health) Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
Figure 52. PPD(Pharmaceutical Product Development) Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
Figure 53. Laboratory Corporation Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
Figure 54. Syneos Health Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
Figure 55. Parexel Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
Figure 56. Covance Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
Figure 57. Charles River Laboratories Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
Figure 58. Wuxi AppTec Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
Figure 59. Pharmaron Inc. Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
Figure 60. Hangzhou Tigermed Consulting Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
Figure 61. IQVIA Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
Figure 62. Joinn Laboratories (China) Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Chemical Drug Research And Development
Table 3. Key Players of Biological Drug Research And Development
Table 4. Key Players of Traditional Chinese Medicine Research And Development
Table 5. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Region (2020-2025)
Table 9. Global Pharmaceutical R&D Outsourcing Services (CRO) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Region (2026-2031)
Table 11. Pharmaceutical R&D Outsourcing Services (CRO) Market Trends
Table 12. Pharmaceutical R&D Outsourcing Services (CRO) Market Drivers
Table 13. Pharmaceutical R&D Outsourcing Services (CRO) Market Challenges
Table 14. Pharmaceutical R&D Outsourcing Services (CRO) Market Restraints
Table 15. Global Pharmaceutical R&D Outsourcing Services (CRO) Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Players (2020-2025)
Table 17. Global Top Pharmaceutical R&D Outsourcing Services (CRO) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical R&D Outsourcing Services (CRO) as of 2024)
Table 18. Ranking of Global Top Pharmaceutical R&D Outsourcing Services (CRO) Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Pharmaceutical R&D Outsourcing Services (CRO) Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Pharmaceutical R&D Outsourcing Services (CRO), Headquarters and Area Served
Table 21. Global Key Players of Pharmaceutical R&D Outsourcing Services (CRO), Product and Application
Table 22. Global Key Players of Pharmaceutical R&D Outsourcing Services (CRO), Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Pharmaceutical R&D Outsourcing Services (CRO) Revenue Market Share by Type (2020-2025)
Table 26. Global Pharmaceutical R&D Outsourcing Services (CRO) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Pharmaceutical R&D Outsourcing Services (CRO) Revenue Market Share by Type (2026-2031)
Table 28. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Pharmaceutical R&D Outsourcing Services (CRO) Revenue Market Share by Application (2020-2025)
Table 30. Global Pharmaceutical R&D Outsourcing Services (CRO) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Pharmaceutical R&D Outsourcing Services (CRO) Revenue Market Share by Application (2026-2031)
Table 32. North America Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Country (2026-2031) & (US$ Million)
Table 47. IQVIA HOLDINGS Company Details
Table 48. IQVIA HOLDINGS Business Overview
Table 49. IQVIA HOLDINGS Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 50. IQVIA HOLDINGS Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025) & (US$ Million)
Table 51. IQVIA HOLDINGS Recent Development
Table 52. ICON (incl. PRA Health) Company Details
Table 53. ICON (incl. PRA Health) Business Overview
Table 54. ICON (incl. PRA Health) Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 55. ICON (incl. PRA Health) Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025) & (US$ Million)
Table 56. ICON (incl. PRA Health) Recent Development
Table 57. PPD(Pharmaceutical Product Development) Company Details
Table 58. PPD(Pharmaceutical Product Development) Business Overview
Table 59. PPD(Pharmaceutical Product Development) Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 60. PPD(Pharmaceutical Product Development) Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025) & (US$ Million)
Table 61. PPD(Pharmaceutical Product Development) Recent Development
Table 62. Laboratory Corporation Company Details
Table 63. Laboratory Corporation Business Overview
Table 64. Laboratory Corporation Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 65. Laboratory Corporation Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025) & (US$ Million)
Table 66. Laboratory Corporation Recent Development
Table 67. Syneos Health Company Details
Table 68. Syneos Health Business Overview
Table 69. Syneos Health Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 70. Syneos Health Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025) & (US$ Million)
Table 71. Syneos Health Recent Development
Table 72. Parexel Company Details
Table 73. Parexel Business Overview
Table 74. Parexel Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 75. Parexel Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025) & (US$ Million)
Table 76. Parexel Recent Development
Table 77. Covance Company Details
Table 78. Covance Business Overview
Table 79. Covance Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 80. Covance Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025) & (US$ Million)
Table 81. Covance Recent Development
Table 82. Charles River Laboratories Company Details
Table 83. Charles River Laboratories Business Overview
Table 84. Charles River Laboratories Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 85. Charles River Laboratories Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025) & (US$ Million)
Table 86. Charles River Laboratories Recent Development
Table 87. Wuxi AppTec Company Details
Table 88. Wuxi AppTec Business Overview
Table 89. Wuxi AppTec Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 90. Wuxi AppTec Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025) & (US$ Million)
Table 91. Wuxi AppTec Recent Development
Table 92. Pharmaron Inc. Company Details
Table 93. Pharmaron Inc. Business Overview
Table 94. Pharmaron Inc. Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 95. Pharmaron Inc. Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025) & (US$ Million)
Table 96. Pharmaron Inc. Recent Development
Table 97. Hangzhou Tigermed Consulting Company Details
Table 98. Hangzhou Tigermed Consulting Business Overview
Table 99. Hangzhou Tigermed Consulting Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 100. Hangzhou Tigermed Consulting Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025) & (US$ Million)
Table 101. Hangzhou Tigermed Consulting Recent Development
Table 102. IQVIA Company Details
Table 103. IQVIA Business Overview
Table 104. IQVIA Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 105. IQVIA Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025) & (US$ Million)
Table 106. IQVIA Recent Development
Table 107. Joinn Laboratories (China) Company Details
Table 108. Joinn Laboratories (China) Business Overview
Table 109. Joinn Laboratories (China) Pharmaceutical R&D Outsourcing Services (CRO) Product
Table 110. Joinn Laboratories (China) Revenue in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025) & (US$ Million)
Table 111. Joinn Laboratories (China) Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
Table 115. Authors List of This Report
List of Figures
Figure 1. Pharmaceutical R&D Outsourcing Services (CRO) Picture
Figure 2. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Type: 2024 VS 2031
Figure 4. Chemical Drug Research And Development Features
Figure 5. Biological Drug Research And Development Features
Figure 6. Traditional Chinese Medicine Research And Development Features
Figure 7. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Application: 2024 VS 2031
Figure 9. Drug Discovery And Early Research Case Studies
Figure 10. Preclinical Research Case Studies
Figure 11. Clinical Trials Case Studies
Figure 12. Post-Marketing Follow-Up Case Studies
Figure 13. Other Case Studies
Figure 14. Pharmaceutical R&D Outsourcing Services (CRO) Report Years Considered
Figure 15. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Region: 2024 VS 2031
Figure 18. Global Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Players in 2024
Figure 19. Global Top Pharmaceutical R&D Outsourcing Services (CRO) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical R&D Outsourcing Services (CRO) as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Pharmaceutical R&D Outsourcing Services (CRO) Revenue in 2024
Figure 21. North America Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Country (2020-2031)
Figure 23. United States Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Country (2020-2031)
Figure 27. Germany Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Region (2020-2031)
Figure 35. China Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Country (2020-2031)
Figure 43. Mexico Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Pharmaceutical R&D Outsourcing Services (CRO) Market Share by Country (2020-2031)
Figure 47. Turkey Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Pharmaceutical R&D Outsourcing Services (CRO) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. IQVIA HOLDINGS Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
Figure 51. ICON (incl. PRA Health) Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
Figure 52. PPD(Pharmaceutical Product Development) Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
Figure 53. Laboratory Corporation Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
Figure 54. Syneos Health Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
Figure 55. Parexel Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
Figure 56. Covance Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
Figure 57. Charles River Laboratories Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
Figure 58. Wuxi AppTec Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
Figure 59. Pharmaron Inc. Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
Figure 60. Hangzhou Tigermed Consulting Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
Figure 61. IQVIA Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
Figure 62. Joinn Laboratories (China) Revenue Growth Rate in Pharmaceutical R&D Outsourcing Services (CRO) Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232